For example, Nrf2 activation in astrocytes confers protection against neurodegeneration in mouse models of ALS [121], and Nrf2 deficiency results in increased sensitivity to MPTP-induced PD-like lesions in mice which is improved by Nrf2 overexpression in astrocytes [122]. This evidence concerns the gene NFE2L2 and Parkinson disease.